Adial Pharmaceuticals, Inc. Form PRE 14A: Preliminary proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-08-11: Form PRE 14A; Period of report 2026-08-10; Description PROXY STATEMENT; Document ea0299259-01.htm.
- 2025-12-23: Form PRE 14A; Period of report 2025-12-23; Description PRELIMINARY PROXY STATEMENT; Document ea0270782-pre14a_adialpharma.htm.
- 2025-05-23: Form PRE 14A; Period of report 2025-05-23; Description PROXY STATEMENT; Document ea0243378-01.htm.
- 2023-11-24: Form PRE 14A; Period of report 2023-11-24; Description PRELIMINARY PROXY STATEMENT; Document ea188727-pre14a_adialpharma.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-08-11 | PRE 14A | 2026-08-10 | PROXY STATEMENT | ea0299259-01.htm |
| 2025-12-23 | PRE 14A | 2025-12-23 | PRELIMINARY PROXY STATEMENT | ea0270782-pre14a_adialpharma.htm |
| 2025-05-23 | PRE 14A | 2025-05-23 | PROXY STATEMENT | ea0243378-01.htm |
| 2023-11-24 | PRE 14A | 2023-11-24 | PRELIMINARY PROXY STATEMENT | ea188727-pre14a_adialpharma.htm |
| 2023-02-24 | PRE 14A | 2023-02-24 | PRELIMINARY PROXY STATEMENT | ea174252-pre14a_adialpharma.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |